Possible mechanism of hematopietic stem cells homing to the bone marrow microenvironment
Possible mechanism of hematopietic stem cells homing to the bone marrow microenvironment
批准号:
13671048
负责人:
MAEKAWA Taira
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We found that the stromal cell derived factor-1/pre-B cell growth stimulating factor (SDF1/PBSF) receptor, CXCR4, is expressed on human CD34^+ bone marrow (BM) cells. Stringently FACS-sorted CD34^+CXCR4^+ BM cells completely lack myeloid, erythroid, megakaryocytic, and mixed colony forming potential (myeloid progenitors), but give rise to B and T lymphoid progenitors, whereas CD34^+CXCR4^- BM cells can generate colonies formed by myeloid progenitors and can also develop into these lymphoid progenitors. Therefore, expression of CXCR4 on CD34^+ BM cells can allow lymphoid progenitors to be discriminated from myeloid progenitors. Since CD34^+CXCR4^+ cells are differentiated from CD34^+CXCR4^- cells, multipotential progenitors located in the BM are likely to be negative for CXCR4 expression. CXCR4 seems to be expressed earlier than the interleukin-7 receptor and terminal deoxynucleotidyl transferase during early lymphohemopoiesis. These results suggest that the expression of CXCR4 on CD34^+ BM cells is one of the phenotypic alterations for committed lymphoid progenitors.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kuroda, J.et al.: "The third-generation bisphosphonate Zoldronate synergistically augments the anti-Ph+ leukemia"Blood. (印刷中). (2003)
Kuroda, J. 等人:“第三代双膦酸盐 Zoldronate 协同增强抗 Ph+ 白血病”(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ma, R., Wada, M., Yoshino, H., Ebihara, Y., Ishii, T., Manabe, A., Tanaka, R., Maekawa. T., Itoh, M., Mugishima, H., Asano, S., Nakahata, T., Tsuji, K.: "Development of human lymphohematopoietic stem/progenitor cells defined by CD34 and CD81 expressions"B
马,R.,和田,M.,吉野,H.,海老原,Y.,石井,T.,真锅,A.,田中,R.,前川。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoshimatsu T et al.: "Prompt and durable hematopoietic reconstitution by unrelated cord blood transplantation in a child with Fanconi anemia"Bone Marrow Transplantation. 27. 767-769 (2001)
Yoshimatsu T 等人:“通过无关的脐带血移植对患有范可尼贫血的儿童进行迅速和持久的造血重建”骨髓移植。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoshimasu, T.et al.: "MxA protein expression in patients with virol infection after allogeneic stem cell transplantation"Bone Marrow Transplantation. (印刷中). (2003)
Yoshimasu, T. 等人:“同种异体干细胞移植后病毒感染患者的 MxA 蛋白表达”,骨髓移植(2003 年出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 23 条
Eradication of chronic myelogenous leukemia stem cells and abnormal clone with T315I point mutation
-
批准号:21390293
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.07万
-
财政年份:2009
-
负责人:MAEKAWA Taira
-
依托单位:
Molecular therapeutics for imatinib-resistant Ph-positive leukemias with newly developed Bcr-Abl/Lyn tyrosine kinase inhibitor
-
批准号:18390283
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.86万
-
财政年份:2006
-
负责人:MAEKAWA Taira
-
依托单位:
Development of Antisense Therapy for Hematological Mailgnancies Targeted Their Rearranged Genes.
-
批准号:11670983
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:MAEKAWA Taira
-
依托单位:
Establishment of Antisense Therapy for Hematological Mailg-nancies Targeted Their Rearranged Genes.
-
批准号:09671094
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1997
-
负责人:MAEKAWA Taira
-
依托单位:
BASIC RESEARCH ON GENE THERAPY FOR HUMAN LEUKEMIAS BY ANTISENSE OLIGODEOXYNUCLEOTIDES
-
批准号:04671531
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1992
-
负责人:MAEKAWA Taira
-
依托单位:
海外基金